1. Scott RD. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf. Published March 2009. Accessed November 30, 2015.
  2. Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605-627.
  3. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
  4. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999; 20(11):725-730.
  5. Harris R. Analysis of surgical site infection rates and cost benefits associated with plain gauze dressings compared to gauze dressings impregnated with Polyhexamethylene Biguinanide (PHMB). Am J Infect Control. 2008; 36(5):E31-E32.